The global entacapone market is anticipated to grow at a significant CAGR during the forecast period. Entacapone is used by combining with levodopa/carbidopa for the treatment of the end-of-dose “wearing-off” effect in patients with Parkinson’s disease. Parkinson’s disease is a disorder of the central nervous. It is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. The major factor for the growth of the market is the increasing prevalence of Parkinson disease.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/entacapone-market
According to the Parkinson Foundation, almost one million people are living with Parkinson disease in the US which is expected to rise to 1.2 million in 2030. Additionally, approximately 60,000 Americans are diagnosed with PD each year and more than 10 million people are living with PD globally. Further, PD disease increases with age however, an estimated 4% of people with PD are diagnosed before age 50. Moreover, the prevalence of PD in men are 1.5 times as compared to women. However, increasing cost for the treatment of PD is hampering the growth of the global entacapone market during the forecast period.
Some major key players in the market include Novartis International AG, Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2021, STADA declared European launch of the Lecigon triple-combination of levodopa, carbidopa, and entacapone for treating advanced Parkinson’s disease.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Product
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape-Novartis International AG, Teva Pharmaceutical Industries Ltd.,and Sun Pharmaceutical Industries Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Entacapone Market Report by Segment
By Product
- Purity:98%
- Purity: above 98%
By Application
- Tablet Product
- Capsule Product
- Others
A full report of Entacapone Market is available at: https://www.omrglobal.com/industry-reports/entacapone-market
Entacapone Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
